Top Tweets for #EffPac
I’ll put myself in the weirdest positions and later complain about my back
Meet us this Saturday at CIRSE 2022 and be amazed by the outstanding outcomes of our peripheral DCB at 5 years follow up.
#EffPac #clinicaltrial #endovascular #CIRSE2022
EffPac Trial has demonstrated at LINC 2022 that our paclitaxel DCB maintains astonishing safety and efficacy outcomes at 5 years. Presented by Dr Teichgräber (PI). #clinicaltrials #LINC2022 #EffPac
Join us today at LINC 2022, and learn about the latest clinical evidence of our DCB at long term follow up. Visit us at booth 33. #LINC2022 #iVascular #EffPac #clinicaltrials
Luminor DCB in the femoropopliteal segment: Outstanding safety and efficacy outcomes in the EffPac and TINTIN trials (Dr Koen Deloose, Dr Tjun Tang and Dr Ulf Teichgräber) – https://t.co/R2tDUXUeWm
@DrDeloose @iVascularGlobal
#Luminor #DCB #TINTIN #EffPac
EFFPAC Trial 2-year outcomes have been presented at LINC 2020 by Dr Scheinert. Luminor demonstrates the best safety and efficacy and that not all DCBs are the same. Our proprietary nanotechnology TransferTech makes the difference.
#LINC2020 #clinicaltrials #EFFPAC #iVascular
Experts discuss latest results from #EFFPAC and #TINTIN trials presented at #CIRSE2019 (This video is only intended for healthcare professionals outside the USA). Watch the full video here: https://t.co/pN70WeAHDx @iVascularToday @cirsesociety @IN_publishing @DrDeloose @UKJ_Jena
Read more about #EFFPAC trial outstanding 2-year safety and efficacy outcomes, at Vascular News coverage of the latest presentation at CRISE 2019. https://t.co/YsCpUdhtB3
#iVastriam #iVascular #luminorDCB
Dr @DrDeloose has revealed the 6-month results of TINTIN Trial. “The combination of luminor DCB and iVolution self-expanding stent, shows impressive 6-month results in lesions of 24cm “ -said Dr Deloose.
For more information visit booth No.45
#CIRSE2019 #iVascular #EFFPAC
Prof Ulf Teichgräber has presented the 24-month outcomes of the EFFPAC Trial at CIRSE 2019. “Astonishing TLR results at 2 years” ...”EFFPAC goes ahead from other DCB trials in effectiveness and safety”. For more information visit our booth No. 45 #CIRSE2019 #iVascular #EFFPAC
Two-year trial data show “astonishing results” for luminor DCB (Ulf Teichgräber) - https://t.co/w8rq2al3vu @PCRonline @iVascularGlobal @UniJena @CN_publishing #EuroPCR2019 #EFFPAC, #luminor #DCB #balloonangioplasty #TLR #restenosis
Lluís Duocastella, CEO of #iVascular, congratulates Prof Ulf Teichgräber, PI of the EFFPAC trial, for the great presentation. We are proud of the astonishing outcomes luminor DCB. #EFFPAC #EuroPCR
Last Seen Hashtags on Sotwe
katibaAt11
Seen from Brazil
transgirl
Seen from Brazil
เนสนี่
Seen from Thailand
NPW2021
Seen from Germany
字母圈
Seen from United States
minichat
Seen from Australia
mythebarn
Seen from United Arab Emirates
psychologyteacher
Seen from United States
男大
Seen from Vietnam
NjooTukujenge
Seen from United States
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.9M followers
Cristiano Ronaldo
@cristiano
114.6M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.2M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers